| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $663K | — | +0.0% |
| R&D Expense | $698K | -81.6% | -59.8% |
| SG&A Expense | $2.1M | +13.9% | -19.1% |
| Operating Income | -$4.1M | +28.2% | -9.6% |
| Pre-tax Income | $1.8M | +118.4% | +194.7% |
| Income Tax | -$35K | -0.0% | -399.7% |
| Net Income | $1.9M | +118.8% | +195.9% |
| EPS (Basic) | $0.41 | +109.3% | +133.3% |
| EPS (Diluted) | -$0.77 | +82.5% | +37.4% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.2M | +62.4% | +410.3% |
| Accounts Receivable | $1.1M | — | +3021.1% |
| Current Assets | $23.4M | +67.6% | +431.7% |
| Total Assets | $36.6M | +33.8% | +101.4% |
| Current Liabilities | $2.6M | -49.5% | +21.2% |
| Total Liabilities | $6.9M | -53.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.2M | -169.6% | — |
| Financing Cash Flow | $17.9M | +450.6% | — |
| +56.0% |
| Stockholders' Equity | $29.7M | +137.4% | +116.0% |